Passer à la navigation principale Passer à la recherche Passer au contenu principal

Phage therapy

  • Mikael Skurnik
  • , Sivan Alkalay-Oren
  • , Maarten Boon
  • , Martha Clokie
  • , Thomas Sicheritz-Pontén
  • , Krystyna Dąbrowska
  • , Graham F. Hatfull
  • , Ronen Hazan
  • , Matti Jalasvuori
  • , Saija Kiljunen
  • , Rob Lavigne
  • , Danish J. Malik
  • , Ran Nir-Paz
  • , Jean Paul Pirnay
    • University of Helsinki
    • The Hebrew University of Jerusalem
    • Hadassah University Medical Center
    • KU Leuven
    • University of Leicester
    • University of Copenhagen
    • AIMST University
    • Polish Academy of Sciences
    • Wroclaw University of Science and Technology
    • University of Pittsburgh
    • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-traditional Antibacterial Therapy (ESGNTA)
    • University of Jyväskylä
    • Loughborough University

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    35 Citations (Scopus)

    Résumé

    Bacteriophage (phages) are viruses that exclusively use bacterial cells for propagation, killing the bacterial host in the process. In phage therapy, phages are used to reduce bacterial numbers, thereby curing bacterial infections. Although this principle is conceptually straightforward, its practical application faces several hurdles. In this Primer, the practical aspects of phage therapy are outlined. We introduce the microbiological methods used to prepare and characterize phages and elucidate their interactions with bacteria. The discussion covers how the information in complete phage genome sequences is used, along with how RNA sequencing can enhance our understanding of phage biology. Selection parameters for therapeutic phages for clinical applications and key elements in industrial-scale phage production are provided. A summary of clinical trials both past and present, phage administration and dosing issues is analysed, as well as limitations associated with phage therapy and mitigation strategies. Finally, we speculate on the future of phage therapy.

    langue originaleAnglais
    Numéro d'article9
    journalNature Reviews Methods Primers
    Volume5
    Numéro de publication1
    Les DOIs
    étatPublié - déc. 2025

    Empreinte digitale

    Examiner les sujets de recherche de « Phage therapy ». Ensemble, ils forment une empreinte digitale unique.

    Contient cette citation